Related references
Note: Only part of the references are listed.Regression of Prostate Tumors Upon Combination of Hormone Ablation Therapy and Celecoxib In Vivo
Parisa Abedinpour et al.
PROSTATE (2011)
The amino-terminal peptide of Bax perturbs intracellular Ca2+ homeostasis to enhance apoptosis in prostate cancer cells
Na Li et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2009)
Ca2+ Signaling, Mitochondria and Cell Death
Paolo Pinton et al.
CURRENT MOLECULAR MEDICINE (2008)
Smooth muscle cell calcium activation mechanisms
Michael J. Berridge
JOURNAL OF PHYSIOLOGY-LONDON (2008)
Desipramine-induced apoptosis in human PC3 prostate cancer cells:: Activation of JNK kinase and caspase-3 pathways and a protective role of [Ca2+]i elevation
Hong-Chiang Chang et al.
TOXICOLOGY (2008)
Inhibition of Akt pathways in the treatment of prostate cancer
E. C. Nelson et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2007)
COX-2 inhibition: A possible role in the management of prostate cancer?
P. Sooriakumaran et al.
JOURNAL OF CHEMOTHERAPY (2007)
Calcium microdomains: Organization and function
Michael J. Berridge
CELL CALCIUM (2006)
Extracellular calcium as a candidate mediator of prostate cancer skeletal metastasis
Jinhui Liao et al.
CANCER RESEARCH (2006)
Celecoxib versus placebo for men with prostate cancer and a rising serum prostate-specific antigen after radical prostatectomy and/or radiation therapy
MR Smith et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Safrole-induced Ca2+ mobilization and cytotoxicity in human PC3 prostate cancer cells
HC Chang et al.
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION (2006)
Celecoxib inhibits prostate cancer growth: Evidence of a cyclooxygenase-2-independent mechanism
MI Patel et al.
CLINICAL CANCER RESEARCH (2005)
Cyclooxygenase-2: How good is it as a target for cancer chemoprevention?
MA Hull
EUROPEAN JOURNAL OF CANCER (2005)
Effects of nonsteroidal anti-inflammatory drugs on bone formation and soft-tissue heating
LE Dahners et al.
JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS (2004)
Novel insights and therapeutical applications in the field of inhibitors of COX-2
W Kiefer et al.
CURRENT MEDICINAL CHEMISTRY (2004)
Single-dose and steady-state pharmacokinetics of celecoxib in children
D Stempak et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2002)
The cyclo-oxygenase-2 inhibitor celecoxib perturbs intracellular calcium by inhibiting endoplasmic reticulum Ca2+-ATPases:: a plausible link with its anti-tumour effect and cardiovascular risks
AJ Johnson et al.
BIOCHEMICAL JOURNAL (2002)
Mechanism underlying histamine-induced intracellular Ca2+ movement in PC3 human prostate cancer cells
KC Lee et al.
PHARMACOLOGICAL RESEARCH (2001)
Share Paper
